Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Sermorelin

GHRH (1-29), GRF 1-29 NH2, Sermorelin acetate

Quick Stats
Studies 223
Trials 41
Score 3
2015 pubmed 27 citations

Operation resistance: A snapshot of falsified antibiotics and biopharmaceutical injectables in Europe.

Venhuis. Bastiaan J BJ; Keizers. Peter H J PH; Klausmann. Rüdiger R; Hegger. Ingrid I

Key Findings

  • Around 21,000 dose units of falsified antibiotics were seized across multiple European countries.
  • Only a few falsified biopharmaceutical injectables were reported, but they included sermorelin, human growth hormone, and melanotan II.
  • The shipment sizes for these injectables were unusually large, suggesting they were intended for resale rather than personal experimentation.

Practical Outcomes

  • If you use or plan to use sermorelin or similar peptides, source them only from trusted, verified suppliers and consider third‑party testing to confirm authenticity. Be aware that counterfeit injectables lack proper labeling and may contain harmful or inactive ingredients, posing health risks. This information highlights the need for vigilance when purchasing peptides, especially from non‑regulated channels.

Summary

The study looked at fake antibiotics and injectable drugs like sermorelin that were seized across Europe during a big anti‑counterfeit operation. It found that while most of the seized items were antibiotics, a few bogus injectable products—including human growth hormone, sermorelin, and melanotan II—were also found, often in large shipments meant for resale rather than personal use.

Abstract

Operation Pangea is an annual international week of action combating pharmaceutical crime. In this study, called Operation Resistance, we asked the national agencies in Europe to search for falsified antibiotics and biopharmaceutical injectables (peptides and proteins) amongst the medicines seized in Pangea 7 (2014). Reports were received from Belgium, Cyprus, Czech Republic, Denmark, France, the Netherlands, Portugal, Sweden, Spain, the United Kingdom, Norway, and Switzerland. The countries reported seizing about 21,000 dose units (e.g. tablets, capsules) of falsified antibiotics in total. Most of the antibiotics were unlicensed medicines with common antibiotic drugs. In this study week, very few falsified biopharmaceutical injectables were reported. Laboratories reported human growth hormone, sermorelin, melanotan II, and no active ingredients. The average shipment size seemed too large for personal use indicating that a substantial part was intended for resale. This study provides a snapshot of the falsified antibiotics and biopharmaceuticals that enter European countries. How much is actually reaching users during Pangea week - in on other weeks - remains unknown. The shipment sizes indicate falsified antibiotics and biopharmaceuticals are imported for both personal use and resale. The use of antibiotics from unreliable sources is a health risk, contributes to antimicrobial resistance, and may obscure a source of infection from health agencies. The falsified biopharmaceuticals are a health risk because they lack all labelling and may contain unlicensed drugs for injection. It seems important to raise awareness among health-care professionals that falsified medicines in Europe are not restricted to erectile dysfunction drugs. Copyright © 2015 John Wiley & Sons, Ltd.

Study Information

Provider

pubmed

Year

2015

Date

2015-10-12T00:00:00.000Z

DOI

10.1002/dta.1888

Citations

27

References

17